VanEck Associates’s CareTrust REIT CTRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.44M | Buy |
159,505
+34,134
| +27% | +$1.34M | ﹤0.01% | 772 |
|
|
2026
Q1 | $4.59M | Buy |
125,371
+14,622
| +13% | +$562K | ﹤0.01% | 836 |
|
|
2025
Q4 | $4M | Buy |
110,749
+8,704
| +9% | +$312K | ﹤0.01% | 850 |
|
|
2025
Q3 | $3.54M | Buy |
102,045
+60,548
| +146% | +$1.99M | ﹤0.01% | 877 |
|
|
2025
Q2 | $1.27M | Buy |
41,497
+4,384
| +12% | +$126K | ﹤0.01% | 1021 |
|
|
2025
Q1 | $1.06M | Buy |
37,113
+1,942
| +6% | +$52.1K | ﹤0.01% | 1034 |
|
|
2024
Q4 | $951K | Buy |
35,171
+10,655
| +43% | +$318K | ﹤0.01% | 1041 |
|
|
2024
Q3 | $756K | Buy |
24,516
+3,777
| +18% | +$107K | ﹤0.01% | 1031 |
|
|
2024
Q2 | $521K | Buy |
20,739
+3,542
| +21% | +$87.7K | ﹤0.01% | 1070 |
|
|
2024
Q1 | $419K | Buy |
17,197
+3,158
| +22% | +$71.3K | ﹤0.01% | 1088 |
|
|
2023
Q4 | $314K | Buy |
14,039
+2,309
| +20% | +$51.1K | ﹤0.01% | 1106 |
|
|
2023
Q3 | $240K | Buy |
11,730
+486
| +4% | +$9.83K | ﹤0.01% | 1132 |
|
|
2023
Q2 | $223K | Buy |
11,244
+413
| +4% | +$8.07K | ﹤0.01% | 1162 |
|
|
2023
Q1 | $212K | Buy |
10,831
+817
| +8% | +$16K | ﹤0.01% | 1156 |
|
|
2022
Q4 | $186K | Buy |
10,014
+4,448
| +80% | +$83K | ﹤0.01% | 1116 |
|
|
2022
Q3 | $101K | Sell |
5,566
-3,193
| -36% | -$65.1K | ﹤0.01% | 1171 |
|
|
2022
Q2 | $162K | Buy |
8,759
+116
| +1% | +$2.06K | ﹤0.01% | 1113 |
|
|
2022
Q1 | $167K | Buy |
8,643
+1,131
| +15% | +$22.3K | ﹤0.01% | 1138 |
|
|
2021
Q4 | $171K | Buy |
7,512
+3,012
| +67% | +$63.8K | ﹤0.01% | 1135 |
|
|
2021
Q3 | $91K | Buy |
4,500
+608
| +16% | +$13.7K | ﹤0.01% | 1167 |
|
|
2021
Q2 | $90K | Sell |
3,892
-82
| -2% | -$1.93K | ﹤0.01% | 1098 |
|
|
2021
Q1 | $93K | Buy |
3,974
+136
| +4% | +$3.12K | ﹤0.01% | 1013 |
|
|
2020
Q4 | $85K | Buy |
3,838
+957
| +33% | +$18.8K | ﹤0.01% | 926 |
|
|
2020
Q3 | $51K | Buy |
2,881
+547
| +23% | +$9.95K | ﹤0.01% | 938 |
|
|
2020
Q2 | $40K | Buy |
2,334
+1,166
| +100% | +$20.4K | ﹤0.01% | 925 |
|
|
2020
Q1 | $17K | Buy |
1,168
+608
| +109% | +$12.1K | ﹤0.01% | 936 |
|
|
2019
Q4 | $12K | Buy |
+560
| New | +$12.3K | ﹤0.01% | 946 |
|
|
2018
Q3 | – | Sell |
-3,781
| Closed | -$63K | – | 803 |
|
|
2018
Q2 | $63K | Hold |
3,781
| – | – | ﹤0.01% | 761 |
|
|
2018
Q1 | $51K | Buy |
3,781
+910
| +32% | +$13.5K | ﹤0.01% | 685 |
|
|
2017
Q4 | $48K | Sell |
2,871
-378
| -12% | -$6.99K | ﹤0.01% | 696 |
|
|
2017
Q3 | $62K | Buy |
3,249
+290
| +10% | +$5.43K | ﹤0.01% | 690 |
|
|
2017
Q2 | $55K | Sell |
2,959
-636
| -18% | -$11.5K | ﹤0.01% | 716 |
|
|
2017
Q1 | $60K | Buy |
3,595
+1,389
| +63% | +$21.6K | ﹤0.01% | 793 |
|
|
2016
Q4 | $34K | Sell |
2,206
-342
| -13% | -$4.89K | ﹤0.01% | 794 |
|
|
2016
Q3 | $38K | Buy |
2,548
+6
| +0.2% | +$88 | ﹤0.01% | 796 |
|
|
2016
Q2 | $35K | Sell |
2,542
-107
| -4% | -$1.41K | ﹤0.01% | 767 |
|
|
2016
Q1 | $34K | Hold |
2,649
| – | – | ﹤0.01% | 740 |
|
|
2015
Q4 | $29K | Buy |
2,649
+820
| +45% | +$9.06K | ﹤0.01% | 724 |
|
|
2015
Q3 | $21K | Buy |
+1,829
| New | +$22.1K | ﹤0.01% | 779 |
|
Other funds holding CTRE
VanEck Associates's CTRE Position: Q2 2026 in Review
VanEck Associates increased its CareTrust REIT (CTRE) stake by 27% in Q2 2026, buying an estimated $1.34M and bringing the position to 159,505 shares worth $6.44M. The position accounts for ﹤0.01% of the portfolio, ranked #772.
VanEck Associates first reported a position in CTRE in Q3 2015 and has held it in 39 quarters since. 512 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.
- VanEck Associates held 159,505 shares of CareTrust REIT worth $6.44M as of Q2 2026.
- VanEck Associates bought 34,134 CareTrust REIT shares in Q2 2026, an estimated $1.34M.
- CareTrust REIT made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #772 holding.
- VanEck Associates first reported a position in CareTrust REIT in Q3 2015 and has held it in 39 quarters since.
- 512 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.